New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
Halozyme Therapeutics (HALO)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Cash Flow Statement (USD)
Annual
|
Quarterly
QUARTER ENDING
31-MAR
2012
30-JUN
2012
30-SEP
2012
31-DEC
2012
31-MAR
2013
Net Income
-15.1M
-14.0M
-20.0M
-53.6M
-19.3M
Depreciation
238K
-238K
796K
-796K
295K
Amortization
0
0
0
0
182K
Deferred Taxes
0
0
0
0
0
Change In Working Capital
-6.62M
6.62M
-5.42M
5.42M
5.19M
Other Non Cash Operating Items
2.15M
-2.15M
6.36M
-6.36M
2.87M
Cash From Operations
-19.4M
19.4M
-47.4M
47.4M
-10.8M
Capital Expenditures
0
0
-873K
873K
-534K
Sale of Assets
15.8K
-15.8K
0
0
0
Acquisitions
0
0
0
0
0
Investments
0
0
0
0
-48.9M
Other Investing Activities
0
0
-873K
873K
-534K
Cash from Investing
15.8K
-15.8K
-873K
873K
-49.5M
Dividends Paid
0
0
0
0
0
Sale / Purchase of Stock
83.1M
-83.1M
83.1M
-83.1M
57.3K
Net Borrowings
0
0
0
0
0
Other Financing Cash Flows
0
0
0
0
-309K
Cash From Financing
83.1M
-83.1M
83.1M
-83.1M
-252K
Foreign Exchange Effect
0
0
0
0
0
Net Change in Cash
63.8M
-63.8M
34.8M
-34.8M
-60.5M
Add Metric
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour